IRIS Accounts Production v23.3.1.45 07397097 Board of Directors 1.11.22 31.10.23 31.10.23 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh073970972022-10-31073970972023-10-31073970972022-11-012023-10-31073970972021-10-31073970972021-11-012022-10-31073970972022-10-3107397097ns10:Originalns15:EnglandWales2022-11-012023-10-3107397097ns14:PoundSterlingns10:Original2022-11-012023-10-3107397097ns10:Originalns10:Director12022-11-012023-10-3107397097ns10:Original2022-11-012023-10-3107397097ns10:Original2023-10-3107397097ns10:Originalns10:PrivateLimitedCompanyLtd2022-11-012023-10-3107397097ns10:Originalns10:SmallEntities2022-11-012023-10-3107397097ns10:Originalns10:AuditExempt-NoAccountantsReport2022-11-012023-10-3107397097ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-11-012023-10-3107397097ns10:SmallCompaniesRegimeForAccountsns10:Original2022-11-012023-10-3107397097ns10:Originalns10:FullAccounts2022-11-012023-10-3107397097ns10:Original12022-11-012023-10-3107397097ns10:Originalns10:Director22022-11-012023-10-3107397097ns10:Originalns10:RegisteredOffice2022-11-012023-10-3107397097ns10:Original2022-10-3107397097ns10:Originalns5:CurrentFinancialInstruments2023-10-3107397097ns10:Originalns5:CurrentFinancialInstruments2022-10-3107397097ns5:ShareCapitalns10:Original2023-10-3107397097ns5:ShareCapitalns10:Original2022-10-3107397097ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-10-3107397097ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-10-3107397097ns5:IntangibleAssetsOtherThanGoodwillns10:Original2022-11-012023-10-3107397097ns10:Originalns5:ComputerEquipment2022-11-012023-10-3107397097ns10:Original2021-11-012022-10-3107397097ns10:Originalns5:NetGoodwill2022-10-3107397097ns10:Originalns5:NetGoodwill2023-10-3107397097ns10:Originalns5:NetGoodwill2022-10-3107397097ns10:Originalns5:ComputerEquipment2022-10-3107397097ns10:Originalns5:ComputerEquipment2023-10-3107397097ns10:Originalns5:ComputerEquipment2022-10-3107397097ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-10-3107397097ns10:Originalns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-10-31
REGISTERED NUMBER: 07397097 (England and Wales)















Unaudited Financial Statements

for the Year Ended 31 October 2023

for

MB Medical Ltd

MB Medical Ltd (Registered number: 07397097)






Contents of the Financial Statements
for the Year Ended 31 October 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


MB Medical Ltd

Company Information
for the Year Ended 31 October 2023







DIRECTORS: Dr M D Brazier
A J Hockey





REGISTERED OFFICE: 7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP





REGISTERED NUMBER: 07397097 (England and Wales)





ACCOUNTANTS: Stanbridge Associates Limited
7 Lindum Terrace
Lincoln
Lincolnshire
LN2 5RP

MB Medical Ltd (Registered number: 07397097)

Balance Sheet
31 October 2023

2023 2022
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 2,050 -
2,050 -

CURRENT ASSETS
Debtors 6 9,034 6,000
Cash at bank 49,782 86,520
58,816 92,520
CREDITORS
Amounts falling due within one
year

7

45,796

47,831
NET CURRENT ASSETS 13,020 44,689
TOTAL ASSETS LESS CURRENT
LIABILITIES

15,070

44,689

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 14,970 44,589
SHAREHOLDERS' FUNDS 15,070 44,689

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

MB Medical Ltd (Registered number: 07397097)

Balance Sheet - continued
31 October 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 15 February 2024 and were signed on its behalf by:





Dr M D Brazier - Director


MB Medical Ltd (Registered number: 07397097)

Notes to the Financial Statements
for the Year Ended 31 October 2023

1. STATUTORY INFORMATION

MB Medical Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover represents trading income accrued during the period shown by these financial statements.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% Straight Line

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 3 ) .

MB Medical Ltd (Registered number: 07397097)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
At 1 November 2022
and 31 October 2023 45,000
AMORTISATION
At 1 November 2022
and 31 October 2023 45,000
NET BOOK VALUE
At 31 October 2023 -
At 31 October 2022 -

5. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 November 2022 1,798
Additions 3,075
At 31 October 2023 4,873
DEPRECIATION
At 1 November 2022 1,798
Charge for year 1,025
At 31 October 2023 2,823
NET BOOK VALUE
At 31 October 2023 2,050
At 31 October 2022 -

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 9,034 6,000

MB Medical Ltd (Registered number: 07397097)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Taxation and social security 8,405 10,440
Other creditors 37,391 37,391
45,796 47,831